Liquid Biopsy Accurately Detects Key Genetic Mutations in Most Common Form of Lung Cancer
Study demonstrates the test’s potential as a clinical tool for identifying patients who can benefit from drugs targeting specific mutations.
Read MoreSearch Results for: genetic testing
Proprietary Program Classifies Broader Range of Cancer Risk Genes
A history-weighting algorithm has been shown to upgrade and downgrade variants of uncertain significance to more definitive clinical classifications, with high accuracy.
Read MoreVariant Scoring and Classification Module Supports Clinical NGS Report Consistency
The functionality provides an intuitive interface and workflow for labs to systematically assess the disease-causing potential of genetic variants using clinical guidelines.
Read More
The Value of Diagnostics
The conclusion to our three-part series exploring the value of diagnostics.
Read MorePartners Connect to Examine Asian-Specific Genetic Mutations in Cancer
Singapore General Hospital and Thermo Fisher Scientific are collaborating to study the mutational profiles of cancer patients with Asian ancestry.
Read More